{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:50:26Z","timestamp":1791078626380,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Center for Rare Diseases","award":["A080588"],"award-info":[{"award-number":["A080588"]}]},{"name":"Korea Health 21 R&D Project","award":["A092058"],"award-info":[{"award-number":["A092058"]}]},{"name":"Korea Health 21 R&D Project","award":["FPR08K1301-02210"],"award-info":[{"award-number":["FPR08K1301-02210"]}]},{"name":"WCU Neurocytomics"},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"crossref","award":["03-2009-002"],"award-info":[{"award-number":["03-2009-002"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.expneurol.2010.10.012","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T08:36:07Z","timestamp":1288341367000},"page":"172-179","source":"Crossref","is-referenced-by-count":262,"title":["Altered microRNA regulation in Huntington's disease models"],"prefix":"10.1016","volume":"227","author":[{"given":"Soon-Tae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kon","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Seok","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeon","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keun-Hwa","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kyu","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2010.10.012_bb0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0010","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0015","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1523\/JNEUROSCI.23-12-05020.2003","article-title":"Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease","volume":"23","author":"Bizat","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0020","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nn.2294","article-title":"miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche","volume":"12","author":"Cheng","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2007.11.018","article-title":"Members of the miRNA-200 family regulate olfactory neurogenesis","volume":"57","author":"Choi","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0035","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1073\/pnas.0801689105","article-title":"Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration","volume":"105","author":"Cuellar","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1242\/dmm.002451","article-title":"Mouse models of Huntington disease: variations on a theme","volume":"2","author":"Ehrnhoefer","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cncr.24743","article-title":"Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer","volume":"116","author":"Gao","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0050","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.STR.0000063404.27912.5B","article-title":"Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats","volume":"34","author":"Horiguchi","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0055","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington's disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0060","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1186\/gb-2007-8-8-r173","article-title":"MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system","volume":"8","author":"Kapsimali","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2007.09.020","article-title":"The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila","volume":"131","author":"Karres","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0076-6879(07)31005-7","article-title":"Mammalian stress granules and processing bodies","volume":"431","author":"Kedersha","year":"2007","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0080","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0092-8674(04)00261-2","article-title":"Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA\/miRNA silencing pathways","volume":"117","author":"Lee","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0095","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1371\/journal.pgen.0030135","article-title":"Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism","volume":"3","author":"Lee","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0100","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1471-4159.2007.05044.x","article-title":"Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS\/c-Jun levels and activating ERK\/Akt pathways","volume":"104","author":"Lee","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nn.2183","article-title":"miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis","volume":"11","author":"Lee","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0110","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ana.21788","article-title":"Slowed progression in models of Huntington disease by adipose stem cell transplantation","volume":"66","author":"Lee","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0115","first-page":"e114","article-title":"microRNAs involved in ischemic preconditioning","volume":"40","author":"Lee","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.canlet.2009.05.030","article-title":"MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines","volume":"286","author":"Liu","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.1090599","article-title":"Nuclear export of microRNA precursors","volume":"303","author":"Lund","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.mad.2008.05.004","article-title":"Murine microRNAs implicated in liver functions and aging process","volume":"129","author":"Maes","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0140","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1523\/JNEUROSCI.22-11-04478.2002","article-title":"Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration","volume":"22","author":"Mittoux","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neulet.2007.09.056","article-title":"NF-\u03baB\/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease","volume":"434","author":"Napolitano","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0150","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease","volume":"28","author":"Packer","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0155","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1128\/MCB.01875-08","article-title":"miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA","volume":"29","author":"Pandey","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nsmb.1533","article-title":"miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42","volume":"16","author":"Park","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0165","doi-asserted-by":"crossref","first-page":"11564","DOI":"10.1523\/JNEUROSCI.3796-05.2005","article-title":"Abnormalities of neurogenesis in the R6\/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment","volume":"25","author":"Phillips","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0170","doi-asserted-by":"crossref","first-page":"10820","DOI":"10.1073\/pnas.0800658105","article-title":"Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies","volume":"105","author":"Savas","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0175","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20070823","article-title":"Cerebellar neurodegeneration in the absence of microRNAs","volume":"204","author":"Schaefer","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0180","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2009.09.019","article-title":"MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase","volume":"31","author":"Shaked","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0185","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","article-title":"Transcriptional abnormalities in Huntington disease","volume":"19","author":"Sugars","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0200","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1111\/j.1742-4658.2009.07041.x","article-title":"Sustained activation of ERK1\/2 by NGF induces microRNA-221 and 222 in PC12 cells","volume":"276","author":"Terasawa","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0205","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/carcin\/bgp094","article-title":"The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras","volume":"30","author":"Tsang","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.expneurol.2010.10.012_bb0210","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0220","doi-asserted-by":"crossref","first-page":"25053","DOI":"10.1074\/jbc.M700501200","article-title":"MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster","volume":"282","author":"Xu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00109-008-0403-6","article-title":"MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a","volume":"87","author":"Zhang","year":"2009","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2010.10.012_bb0235","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610003973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610003973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T22:01:46Z","timestamp":1711922506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488610003973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0014488610003973"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.10.012","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}